AZD7624

DRUG4 trials

Sponsors

AstraZeneca, National Jewish Health

Conditions

COPDChronic Obstructive Pulmonary Disease (COPD)Corticosteroid Resistant (CR) AsthmaticsHealthy SubjectsLPS Challenge, Neutrophils

Phase 1

A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects

CompletedNCT01754844

AstraZenecaChronic Obstructive Pulmonary Disease (COPD)

Start: 2013-01-31End: 2013-08-31Updated: 2015-04-02

To Assess the Safety, Tolerability, and Pharmacokinetics of AZD7624 in Healthy Volunteers and COPD Patients

CompletedNCT01817855

AstraZenecaCOPD, Healthy Subjects

Start: 2013-09-30End: 2014-10-31Updated: 2016-03-30

Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin Challenge

CompletedNCT01937338

AstraZenecaLPS Challenge, Neutrophils

Start: 2013-10-31End: 2014-04-30Updated: 2014-05-07

Phase 2

Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma

CompletedNCT02753764

National Jewish HealthCorticosteroid Resistant (CR) Asthmatics

Start: 2017-01-31End: 2019-02-25Updated: 2019-08-21